Sponsored by Zoetis
In today’s episode of Clinician’s Brief Partner Podcast, host Dr. Beth sits down with Dr. Wendy Simpson to discuss the unique challenges cats and their owners face when visiting the veterinary clinic. From the stress of leaving home to the intimidating clinic environment, acute fear and anxiety often inhibit the care cats receive—or prevent visits altogether. Tune in as they discuss strategies for success, including how a novel previsit pharmaceutical can help change the way we approach feline care.
Contact us:
Podcast@briefmedia.com
Where to find us:
Twitter:
Instagram:
The Team:
Beth Molleson, DVM - Host
Sarah Pate - Producer & Project Manager, Brief Studio
Randall Stupka - Podcast Production & Sound Editing
Bonqat is the first and only FDA-approved treatment for alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
IMPORTANT SAFETY INFORMATION:
See full Prescribing Information. Not for human use. Do not use in cats with known hypersensitivity to pregabalin. Use with caution in cats with cardiac disease, hypertension, renal disease, or severe systemic disorders. The safe use of BONQAT has not been evaluated in breeding, pregnant, or lactating cats; in cats younger than 7 months of age; in cats with cardiac disease, hypertension, renal disease, or severe systemic disorders; or in conjunction with opioids and other sedatives. The most common side effects are in coordination, lethargy, and vomiting.
